We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · June 05, 2021

Consequences of Lapses in Treatment With VEGF Inhibitors in nAMD in Routine Clinical Practice

Retina (Philadelphia, Pa.)


Additional Info

Retina (Philadelphia, Pa.)
Consequences of Lapses in Treatment With Vascular Endothelial Growth Factor Inhibitors in Neovascular Age-Related Macular Degeneration in Routine Clinical Practice
Retina (Philadelphia, Pa.) 2021 Mar 01;41(3)581-587, TE Greenlee, VY Wang, H Kang, ME Ohlhausen, AX Chen, GL Hom, TF Conti, I Briskin, AS Babiuch, RP Singh

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading